Health Catalyst HCAT Technology — Adjusted cost of revenue

Similar metrics at other companies

DUOTTechnology Solutions — Cost Of Revenue

$506.57K+533%

DUOTTechnology Service — Cost Of Revenue

$17.55K-92.4%

FIVNReportable Segment — Cost of Revenue, Adjusted

$111.01M+5.6%

XRAYConnected Technology Solutions — Adjusted cost of products sold

$156M+15.6%

DFINTechnology Service — Cost Of Goods And Service Excluding Depreciation Depletion And Amortization

$26.8M-1.8%

DGIIAmortization of acquired technology

$1.52M+59.6%

Questions, answered.

What is Health Catalyst's technology — adjusted cost of revenue?

Health Catalyst (HCAT) reported technology — adjusted cost of revenue of $17.16M in Q1 2026.

How has Health Catalyst's technology — adjusted cost of revenue changed year-over-year?

Health Catalyst's technology — adjusted cost of revenue increased by 1.7% year-over-year, from $16.87M to $17.16M.

What is the long-term trend for Health Catalyst's technology — adjusted cost of revenue?

Over 3 years (2022 to 2025), Health Catalyst's technology — adjusted cost of revenue has grown at a 8.0% compound annual growth rate (CAGR), from $54M to $67.96M.

What does technology — adjusted cost of revenue mean?

This metric measures the direct costs associated with delivering technology-based services and products, adjusted to exclude non-cash items like depreciation and amortization. It reflects the cash-based operational expenses required to support cloud platforms and software subscriptions. Monitoring this helps evaluate the direct cost efficiency and variable expense management within the technology segment.